FDA Approves Merck’s New Drug For A Rare Lung Disease
Forbes Healthcare
MARCH 26, 2024
The pharmaceutical giant’s new treatment, sotatercept, showed significant benefits for the thousands of patients suffering from pulmonary arterial hypertension in clinical trials.
Let's personalize your content